Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 2977-2983

  Dauplat, J ^a   Chene, G ^a,b   Pomel, C ^a   Dauplat, M M ^a,c   Bouëdec, G Le ^a   Mishellany, F ^a   Lagarde, N ^a   Bignon, Y J ^a   Jaffeux, P ^c   Aublet Cuvelier, B ^c   Dechelotte, P ^c   Pouly, J L ^c   Penault Llorca, F ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

BRCA mutation; Ovarian cancer; Ovarian dysplasia; Ovulation induction

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC RISK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CANCER; OVARY EPITHELIUM DYSPLASIA; OVULATION INDUCTION; PRECANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

ADNEXA UTERI; ADULT; FEMALE; FERTILIZATION IN VITRO; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; OVULATION INDUCTION; PRECANCEROUS CONDITIONS;

EID: 70350576878     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.06.012     Document Type: Article

References (44)

1. Ahmed F.Y., Wiltshaw E., Ahern R.P., et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 14 (1996) 2968-2975
2. Menon U., Skates S.J., Lewis S., Rosenthal A.N., Mc Donald N., and Jacobs I.J. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 23 (2005) 7919-7926
3. Brewer M.A., Ranger-Moore J., Baruche A., et al. Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 14 (2005) 299-305
4. Gwinn M.L., Lee N.C., Rhodes P.H., Layde P.M., and Rubin G.L. Pregnancy, breast feeding and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43 (1990) 559-568
5. Wu M.L., Whittemore A.S., Paffenbarger R.S., et al. Personal and environmental characteristics related to epithelial ovarian cancer. Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 128 (1988) 1216-1227
6. Fathalla M. Incessant ovulation: a factor in ovarian neoplasia?. Lancet 2 (1971) 163
7. Deligdish L., Gil J., Kerner H., Wu H.S., Beck D., and Gershoni-Baruch R. Ovarian dysplasia in prophylactic oophorectomy specimens. Cancer 86 (1999) 1544-1550
8. Nieto J.J., Crow J., Sundaresan M., et al. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecol Oncol 82 (2001) 344-349
9. Gusberg S.B., and Deligdish L. Ovarian dysplasia, a study of identical twins. Cancer 54 (1984) 1-4
10. Salazar H., Godwin A.K., Daly M.B., et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 88 (1996) 1810-1820
11. Plaxe S., Deligdish L., Dottino P., and Cohen C. Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol Oncol 38 (1990) 367-372
12. Zheng J., Wan M., Zweizig S., Veliescu M., Yu M.C., and Dubeau L. Histologically benign or low grade malignant tumors adjacent to high grade ovarian carcinomas contain molecular characteristics of high grade carcinomas. Cancer Res 53 (1993) 4138-4142
13. Tressera F., Grases P.J., Labastida R., and Ubeda A. Histological features of the controlateral ovary in patients with unilateral ovarian cancer: a case control study. Gynecol Oncol 71 (1998) 437-441
14. Mittal K.R., Jacquotte A.Z., Cooper J.L., and Demopoulos R. Controlateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol 12 (1993) 59-63
15. Werness B.A., Afify A.M., Bielat K.L., Eltabbakh G.H., Piver M.S., and Paterson J.M. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol 30 (1999) 151-157
16. Stratton J.F., Buckey C.H., Lowe D., and Ponder B.A.J. Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation. J Natl Cancer Inst 91 (1999) 626-681
17. Barakat R.R., Federici M.G., Saigo P.E., Robson M.E., Offit K., and Boyd J. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimen from BRCA1 heterozygotes. Cancer 89 (2000) 383-390
18. Chene G., Penault-Llorca F., Le Bouëdec G., et al. Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk. Int J Gynecol Cancer 19 (2009) 65-72
19. Schloosshauer P.W., Cohen C.J., Penault-Lllorca F., et al. Prophylactic oophorectomy. Cancer 98 (2003) 2599-2606
20. Deligdisch L., and Gil J. Characterization of ovarian dysplasia by interactive morphometry. Cancer 63 (1989) 748-755
21. Deligdisch L., Miranda C., Barba J., and Gil J. Ovarian dysplasia: nuclear texture analysis. Cancer 72 (1993) 3253-3257
22. Berchuck A., Kohler M.F., Boente M.P., Rodriguez G.C., Whitaker R.S., and Bast R.C. Growth regulation and transformation of ovarian epithelium. Cancer 71 (1993) 545-551
23. Wong A.S.T., Maines-Bandiera S.L., Rosen B., et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 81 (1999) 180-188
24. Wong A.S.T., and Auersperg N. Ovarian surface epithelium: family history and early events in ovarian cancer. Reprod Biol Endoc 70 (2003) 1-8
25. Tok E.C., Ertung D., Tataroglu C., Yazici G., Kanat H., and Dilek S. Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women. Int J Gynecol Cancer 16 (2006) 501-506
26. Corakci A., Filiz S., Caliskan E., Dalcik C., Ozeren S., and Dalcik H. The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: an experimental study on rats. Int J Gynecol Cancer 15 (2005) 866-871
27. Whittemore A.S., Harris R., and Itnyre J. And the collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case-control studies. II. Invasive epithelial ovarian cancer in white women. Am J Epidemiol 136 (1992) 1184-1202
28. Harris R., Whittemore A.S., and Itnyre J. And the collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 136 (1992) 1204-1211
29. Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., and Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med 331 (1994) 771-776
30. Chene G., Penault-Llorca F., Le Bouëdec G., et al. Ovarian epithelial dysplasia after ovulation induction: time and dose effect. Human Reprod 24 (2009) 132-138
31. Kurman R.J., and Shih Ie.M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27 (2008) 151-160
32. Dehari R., Kurman R.J., Logani S., and Shih Ie.M. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis. Am J Surg Pathol 31 (2007) 1007-1012
33. Folkins A.K., Jarboe E.A., Roh M.H., and Crum C.P. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 113 (2009) 391-396
34. Crum C.P., Drapkin R., Kindelberger D., Medeiros F., Miron A., and Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5 (2007) 35-44
35. Carcangiu M.L., Radice P., Manoukian S., et al. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy from BRCA1 and BRCA2 germline mutation carriers. Int J Gynecol Pathol 23 (2004) 35-40
36. Mahdavi A., Pejovic T., and Nezhat F. Induction of ovulation and ovarian cancer: a critical review of the literature. Fertil Steril 85 (2006) 819-826
37. Ness R.B., Cramer D.W., and Goodman M.T. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155 (2002) 217-224
38. Shushan A., Paltiel O., Iscovich J., Elchalal U., Peretz Y., and Schenker J.G. Human menopausal gonadotrophin and risk of epithelial ovarian cancer. Fertil Steril 65 (1996) 13-18
39. Parazzini F., Negri E., La Vecchia C., et al. Treatment for infertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 68 (1998) 226-228
40. Sushan A., Paltiel O., and Schencker J.G. Induction of ovulation and borderline ovarian cancer-the hormonal connection?. Eur J Obstet Gynecol Reprod Biol 85 (1999) 1-4
41. Cinton G.M., and Hua W. Estrogen action in human ovarian cancer. Crit Rev Oncol Hematol 25 (1997) 1-9
42. Garg P.P., Kerlikowske K., Subak L., and Grady D. Hormone replacement therapy and the risk of epithelial ovarian cancer: a meta-analysis. Obstet Gynecol 92 (1998) 472-479
43. Chene G., Penault-Llorca F., Le Bouëdec G., et al. Ovarian epithelial dysplasia: myth or reality?. Review Gynecol Obstet Fertil 36 (2008) 800-807
44. Jongsma A.P.M., Piek J.M.J., Zweemer R.P., et al. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. J Clin Pathol Mol Pathol 55 (2002) 305-309